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INT ROD UCT ION
Toxoplasma gondii is transmitted by food or water and in-
fection occurs in many of the animals used for food in the 
United States (Scallan et al., 2011; Hill and Dubey, 2013). 
Human infection can result from the ingestion of under-
cooked or raw meat containing tissue cysts, or from the con-
sumption of water or food contaminated by oocysts excreted 
in the feces of infected cats (Dubey, 1998; Torrey and Yolken, 
2013). Because of the high prevalence of T. gondii, groups 
of individuals with compromised immune systems remain 
at risk of Toxoplasma encephalitis (TE). Indeed, in the early 
years of the HIV epidemic T. gondii was often observed in 
individuals with AIDS, sometimes leading to TE. Even in the 
era of combination antiretroviral therapy, fatal TE still occurs 
in HIV-infected individuals as a result of reactivation of la-
tent infection, and remains a significant problem in AIDS pa-
tients who harbor this chronic parasitic infection (Grant et al., 
1990; Zangerle et al., 1991). TE in HIV-infected individuals 
occurs coincident with the drop in CD4 T cell count (Luft 
and Remington, 1992), thus it is believed that reactivation 
of latent infection during AIDS is caused by reduced CD4 T 
cell help to CD8 T cells.
Although both CD4 and CD8 T cells have been re-
ported to act synergistically to control T. gondii infection, 
CD8 T cells play a dominant role in host protection (Gazz-
inelli et al., 1991, 1992; Khan et al., 1994, 1999). Long-term 
immunity to T. gondii is believed to primarily depend on 
CD8 T cells (Parker et al., 1991), and depletion of this subset 
rather than CD4 T cells results in host mortality (Gazzinelli et 
al., 1992). The synergistic effect of CD4 T cells is most likely 
restricted to their helper role in the maintenance of a long-
lived CD8 T cell response (Casciotti et al., 2002). Importantly, 
although CD4 T cell help most likely plays an important role 
during chronic T. gondii infection, the requirements for per-
sistent CD4 T cell help in the control of chronic infections 
are not well defined. Studies conducted with viral pathogens 
like HBV, HCV, and lymphocytic choriomeningitis virus 
(LCMV) have observed CD4 T cell exhaustion in the infected 
host and it has been suggested that CD4 T cell dysfunction 
effects CD8 T cell functionality (Brooks et al., 2005; Yi et al., 
2010; Crawford et al., 2014; Ye et al., 2015). The requirement 
for CD4 T cell help during chronic infections like toxoplas-
mosis is very crucial as CD8 T cells need to be maintained 
to keep the pathogen under control. Thus, studies focused on 
investigating CD4 T cell functionality during TE are needed. 
Previous studies from our laboratory reported several fold in-
creases in the expression of the inhibitory receptor PD-1 on 
CD8 T cells from mice carrying chronic toxoplasmosis. This 
led to severe exhaustion and loss of functionality of these cells 
(Bhadra et al., 2011, 2012, 2013). In the current study, we 
demonstrate that similar to CD8 T cells, T. gondii–specific 
CD8, but not CD4, T cells are considered critical for control of chronic toxoplasmosis. Although CD8 exhaustion has been 
previously reported in Toxoplasma encephalitis (TE)–susceptible model, our current work demonstrates that CD4 not only be-
come exhausted during chronic toxoplasmosis but this dysfunction is more pronounced than CD8 T cells. Exhausted CD4 pop-
ulation expressed elevated levels of multiple inhibitory receptors concomitant with the reduced functionality and up-regulation 
of Blimp-1, a transcription factor. Our data demonstrates for the first time that Blimp-1 is a critical regulator for CD4 T cell 
exhaustion especially in the CD4 central memory cell subset. Using a tamoxifen-dependent conditional Blimp-1 knockout 
mixed bone marrow chimera as well as an adoptive transfer approach, we show that CD4 T cell–intrinsic deletion of Blimp-1 
reversed CD8 T cell dysfunction and resulted in improved pathogen control. To the best of our knowledge, this is a novel find-
ing, which demonstrates the role of Blimp-1 as a critical regulator of CD4 dysfunction and links it to the CD8 T cell dysfunc-
tionality observed in infected mice. The critical role of CD4-intrinsic Blimp-1 expression in mediating CD4 and CD8 T cell 
exhaustion may provide a rational basis for designing novel therapeutic approaches.
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CD4 T cells have increased expression of inhibitory recep-
tors like PD-1, 2B4 and LAG-3 during chronic infection. 
The parasite-specific CD4 T cells also exhibited decreased 
functionality, which was concomitant with reactivation of in-
fection. Although some common features between exhausted 
CD4 and CD8 T cell exhaustion during chronic viral infec-
tion have been demonstrated (Shin and Wherry, 2007; Craw-
ford et al., 2014), we observed that elevated expression of the 
transcription factor Blimp-1 in T. gondii–specific CD4 T cells 
was responsible for their dysfunction. Conditional deletion 
of Blimp-1 on CD4 T cells restored their functionality and 
reversed CD8 T cell exhaustion, leading to increased ability 
of the host to control infection. These studies link CD8 T 
cell dysfunctionality observed during chronic toxoplasmosis 
to CD4 T cell exhaustion.
RES ULTS
T. gondii–specific CD4 T cells up-regulate inhibitory 
receptors and lose their functionality during 
chronic T. gondii infection
We have previously reported that chronic T. gondii infection 
results in progressive decline in CD8 T cell effector function 
concomitant with PD-1 up-regulation (Bhadra et al., 2011). 
Gazzinelli et al. (1992) demonstrated that depletion of CD8 
T but not CD4 T cells in chronically infected C57BL6 (a 
susceptible mouse strain) results in TE. This led us to hypoth-
esize that CD4 are more severely exhausted than CD8 T cells 
during chronic toxoplasmosis and, as a result, depletion of 
a highly exhausted subset (CD4 T cell) has minimal impact 
on pathogen control. Alternatively, it is possible that CD4 
T cells may not be the relevant subset for T. gondii control 
during chronic infection. We addressed these possibilities by 
determining the functional status of T. gondii–specific CD4 
T cells during chronic T. gondii infection. At first, we com-
pared the expression of inhibitory receptor PD-1 on CD4 
and CD8 T cells from T. gondii–infected animals. In agree-
ment with our previous publication on CD8 T cells, PD-1 
expression on CD4 T cells was up-regulated during early 
chronic phase (5–6 wk p.i.; Fig. 1 A). Significantly, PD-1hi T 
cells were more enriched in CD4 T cell subset than CD8 T 
cell during early chronic phase. Studies related to T cell ex-
haustion, especially with CD8 T cells, have demonstrated that 
in addition to PD-1, up-regulation of other inhibitory recep-
tors (2B4, CTLA4, etc.) can act cooperatively in exacerbating 
dysfunction on T cells (Blackburn et al., 2009; Jin et al., 2010; 
Butler et al., 2011). Significantly, up-regulation of inhibitory 
receptors concomitant with loss of T cell functionality are 
considered hallmarks of T cell exhaustion. Analysis of PD-1hi 
CD4 and CD8 subsets revealed that both PD-1hi CD4 and 
CD8 T cells expressed higher levels of 2B4 and CTLA4 than 
PD-1int or PD-1lo cells (Fig. 1 B). However, PD-1hi CD4 T 
cells expressed significantly greater levels of 2B4 than PD-1hi 
CD8 T cells (Fig. 1 C). To further characterize CD4 T cell 
dysfunction, we observed if down-regulation of co-stimula-
tory receptors on CD4 T cells correlated with increase in 
PD-1 expression on antigen-specific CD4 T cells. T cell sub-
sets expressing different levels of PD-1 (PD-1hi, PD-1int, and 
PD-1lo) were evaluated for the expression of co-stimulatory 
receptors (OX40, ICOS, and 41BB). We observed that during 
early chronic T. gondii infection (5-6 wk p.i.), CD4 PD-1hi 
cells exhibited increased 2B4 (one of inhibitory receptors) 
and decreased ICOS and OX40 (co-stimulatory receptors) 
levels as compared with CD8 PD1hi population (Fig.  1, D 
and E). The aforementioned data suggest that T cell dysfunc-
tion is more pronounced on CD4 T cells than CD8 T cells 
during early chronic phase.
Due to the limited number of class II epitopes defined 
for the T. gondii infection model (Grover et al., 2012), we 
used a surrogate marker strategy that has been successfully 
used by other groups to identify a broader representation of 
antigen-specific T cells (Butler et al., 2011; McDermott and 
Varga, 2011). This approach was validated by screening cells 
from animals infected with T. gondii for surrogate activation 
markers (CD11a and CD49d) and comparing this analysis 
to T. gondii–specific Class II tetramer (AS15) staining. At 3 
and 7 wk p.i., >90% of tetramer+ cells from spleen and brain 
expressed CD11ahi and CD49dhi phenotype (Fig.  2  A). To 
identify the fraction of CD11ahiCD49dhi CD4 T cells that are 
tetramer (AS15) positive, CD11ahiCD49dhi cells were gated 
and analyzed. We observed that 1/5 of CD11ahiCD49dhi cells 
stained positive for tetramer (Fig. 2 B). These findings demon-
strate that among the surrogate marker positive population, 
only 20% are specific for AS15 tetramer. To establish that sur-
rogate marker positive CD4 T cells are antigen specific, the 
cells (CD11ahiCD49dhi) were separated into tetramer-positive 
and -negative population (Fig. 2 C). The two purified pop-
ulations (>98% pure) were injected separately into CD4 KO 
animals and the next day the recipients were infected with T. 
gondii. The proliferation of donor CD4 T cells was measured 
by BrdU incorporation. As shown in Fig. 2 D (top column), 
both tetramer-positive and -negative CD4+CD11ahiCD49dhi 
(surrogate marker positive) exhibited strong proliferation in 
response to T. gondii infection. Interestingly, tetramer-neg-
ative population showed significantly higher proliferation as 
compared with tetramer-positive cells (Fig. 2 D, top column). 
As expected, surrogate marker negative population exhibited 
minimal proliferation in response to T. gondii infection. These 
observations establish that the surrogate marker positive pop-
ulation is T. gondii specific, which responds strongly to re-
call antigen. This is further emphasized by the finding that 
a significantly higher percentage of donor CD4 population 
was observed in the spleens of animals treated with tetramer- 
negative cells from surrogate marker–positive population 
(Fig. 2 D bottom). T. gondii specificity of CD11ahiCD49dhi 
cell population was further established by the observation 
that, unlike the cells bearing CD11aloCD49dlo phenotype, 
the former subset was able to produce cytokines like IFN-γ 
and TNF in response to stimulation with T. gondii antigen 
(Fig. 2 E). Furthermore, most IFN-γ+ cells expressing CD11a 
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which decreased at 7 wk p.i. (Fig. 2 F). In addition, the trend 
of decreased cell numbers of AS15+ (tetramer+) CD4 T cells 
and CD11ahiCD49dhi cells were comparable, although the 
CD11ahiCD49dhi population was ∼10 times more than AS15+ 
cells (Fig. 2, G and H). Thus, to more broadly evaluate the re-
sponse of T. gondii–specific T cells to multiple antigens, our 
investigation focused on CD11ahiCD49dhi T. gondii–specific 
CD4 T cells. We next proceeded to measure the kinetics of 
the CD11ahiCD49dhi T. gondii–specific CD4 T cell response 
after T. gondii infection in spleen and brain. The total cell 
number of splenocytes increased at 3 wk (acute), but signifi-
cantly decreased at 5 wk (early chronic) to 7 wk (late chronic) 
p.i. (Fig.  3  A, top). In contrast, the quantity of T. gondii– 
specific CD4 T cells were elevated at 5 wk in brain, but sub-
sequently decreased at 7 wk p.i. (Fig.  3  A, bottom). Based 
on the decreased number of T. gondii–specific CD4 T cells, 
we sought to evaluate levels of CD11ahiCD49dhi T. gondii– 
specific CD4 T cell exhaustion at 7 wk (late chronic phase). To 
determine if T. gondii–specific CD4 T cells had an exhausted 
phenotype similar to our prior report on CD8 T cells (Bhadra 
et al., 2011), we measured expression of the inhibitory recep-
tor PD-1 at early and late stages of infection. As shown in 
Fig. 3 B, up-regulation of PD-1 expression was observed on 
the CD11ahiCD49hi (T. gondii–specific) population of cells 
in spleen and brain at 7 wk p.i. (Fig. 3, B and C). The mean 
fluorescent intensity (MFI) of PD-1 expression in spleen was 
Figure 1. CD4 T cells express increased 
levels of inhibitory receptors and decreased 
co-stimulatory receptors compared with 
CD8 T cells during early chronic infection. 
C57BL/6 mice were perorally infected with 10 
ME49 tissue cysts and splenocytes harvested 
during early chronic phase (5-6 wk p.i.). (A) PD-
1lo, PD-1Int, and PD-1hi gating was performed 
(left) on splenic CD4 cells (left, top) and CD8 
(left, bottom). Percentage of PD-1hi, PD-1int, 
and PD-1lo expression on CD4 or CD8 at 5-6 
wk p.i. (right). (B) 2B4 and CTLA4 expressions 
on CD4+ PD-1hi and CD8+ PD-1hi. Black line, 
CD4+ PD-1hi; dot line, CD4+ PD-1int; bold line, 
CD4+ PD-1lo (top). Black line, CD8+ PD-1hi; 
dot line, CD8+ PD-1int; bold line, CD8+ PD-1lo 
(bottom). (C), MFI of CTLA4 and 2B4 on CD4 
PD-1hi and CD8 PD-1hi. (D) Multiple co-stim-
ulatory receptors expression on CD4 and CD8 
cells in PD-1lo, PD-1Int, and PD-1hi population 
at 5–6 wk p.i. (E) MFI of OX40, ICOS, and 41BB 
on splenic CD4 and CD8 cells. The data rep-
resents three experiments with at least three 
mice per group. P-values were obtained using 
the Student’s t test. *, P < 0.05; **, P < 0.01; ***, 
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Figure 2. Validation of surrogate markers on antigen-specific CD4 T cells during T. gondii infection. (A) Splenocytes and brain cells were harvested 
at 3 and 7wk p.i., and subsequently stained with anti-CD4 and MHC II-restricted tetramer (AS15). Cells were gated on CD4+AS15+, analyzed by CD11a and 
CD49d surrogate markers (left, spleen; right, brain). (B) Splenocytes were stained for CD4 CD11a and CD49d at 3 wk p.i., and analyzed for the expression MHC 
II-restricted tetramer (AS15). (C) CD4CD11aCD49d population was sorted from the splenocytes of week 3 infected mice. The purified population (>98%) was 
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significantly higher in the T. gondii–specific CD4 population 
at 7 wk p.i. and continued to increase on CD4 T cells in brain 
from 3–7 wk p.i (Fig. 3 C). As sustained expression of PD-1 
is coupled to increased exhaustion and decreased function-
ality of T. gondii–specific CD4 T cells, we hypothesized that 
the PD-1hi population would be associated with other inhib-
itory receptors. There was a significant increase in frequency 
of PD-1hi expressing T. gondii–specific CD4 T cells at 7 wk 
p.i. (Fig. 3 D). Importantly, this population also had increased 
expression of LAG-3 and 2B4 (Fig. 3 E).
To determine if increases in the expression of inhib-
itory receptors correlated with the functionality, cells were 
assayed for the proinflammatory cytokines IFN-γ and TNF 
after stimulation with T. gondii antigen. Although the ab-
solute number of splenic and brain cytokine producing T. 
gondii–specific CD4 T cells increased from 5 wk, there was a 
significant decrease in cytokine-producing cells at 7 wk p.i., 
coincident with their maximal expression of PD-1 (Fig. 4 A). 
Interestingly, the PD-1hi subset of T. gondii–specific CD4 T 
cells in spleen and brain did not show a decrease in function-
ality (unpublished data) at 3 wk p.i. in spleen and at 5 wk 
p.i in brain, similar to our earlier study on CD8 exhaustion 
in which, at earlier time points, PD-1hi population did not 
lose the ability to produce cytokines (Bhadra et al., 2011). 
However, at 7 wk p.i. there was a significant decrease in the 
functionality of PD-1hi expressing T. gondii–specific CD4 T 
cells in both spleen and brain (Fig. 4, B–D). T reg (regulatory 
T) cells have been reported to express increased inhibitory 
receptors, such as CTLA4, among others. However, in the T. 
gondii model, no difference in T reg cell development was 
noted between the early chronic and late chronic infection 
(Fig. 4, E and F), arguing against the possibility of altered T 
reg cell development resulting in differential PD-1 expression 
or loss of IFN-γ during late chronic toxoplasmosis. Collec-
tively, these findings suggest that the expression of inhibitory 
receptors on T. gondii–specific CD4 T cell during chronic 
toxoplasmosis contribute to the diminished ability of the cells 
to recall their effector functions.
Blimp-1 expression on T. gondii–specific CD4 
T cell is correlated with CD4 T cell exhaustion 
during chronic toxoplasmosis
Recent studies have implicated changes in the expression pat-
tern of the transcription factors, (T-bet, Eomes, Blimp-1, and 
Bcl6), being associated with the development of exhaustion 
in CD8 T cells (Shin et al., 2009; Kao et al., 2011; Paley et al., 
2012; Buggert et al., 2014; Crawford et al., 2014). To better 
define the exhausted phenotype in parasite-specific CD4 T 
cells in a T. gondii infection model, we analyzed the expres-
sion pattern of those transcription factors at different time 
points after infection (Fig. 5, A and B). Similar to observations 
noted in CD8 T cells during chronic LCMV infection (Kao 
et al., 2011), we observed that in T. gondii–infected animals, 
concomitant with increased PD-1 levels, T. gondii–specific 
CD4 T cells showed decreased T-bet expression especially on 
the PD-1hi subset (Fig. 5, A and B, panel 1). The PD-1hi CD4 
T cells also exhibited increased levels of Eomes (Fig.  5, A 
and B, panel 2), which was similar to the observations made 
with CD8 T cells from HIV infected individuals that exhib-
ited T-betdimEomeshi expressional profile (Buggert et al., 2014; 
Gupta et al., 2015). Additionally, up-regulation of Blimp-1 an 
important transcriptional factor for CD8 T cell exhaustion 
(Shin et al., 2009), was observed in the CD4 T cell population 
at 7 wk p.i. (Fig. 5, A and B: panel 3). In contrast, a significant 
decrease in Bcl6 levels, a transcription factor considered to be 
a reciprocal antagonist to Blimp-1 (Johnston et al., 2009) and 
important for memory cell differentiation (Kaech and Cui, 
2012), was noted at wk7 p.i. (Fig. 5, A and B, panel 4). To clar-
ify the expression of transcription factors in multiple dimen-
sion, we performed the analysis with Blimp-1 versus different 
transcription factors (T-bet, Eomes, and Bcl6) at 7 wk p.i. 
Consistent with Fig. 5 B, we found that the Blimp-1hi CD4 T 
cells exhibited decreased T-bet and Bcl6 expression, whereas 
increased expression of Eomes was observed on these cells 
(Fig. 5 C). Because the transcription factor Blimp-1 has been 
reported to be important for CD8 T cell exhaustion during 
chronic viral infection (Shin et al., 2009), we next assessed 
its role of regulating the function of T. gondii–specific CD4 
T cells. We first measured the expression of PD-1 in Blimp-
1lo, Blimp-1int and Blimp-1hi CD4 T cell subsets (Fig. 5, D 
and E). As shown in Fig. 5 E, increased Blimp-1 expression 
correlated well with elevated PD-1 expression by these cells. 
Similarly, Blimp-1hi CD4 T cell population also had increased 
levels of other inhibitory markers, including 2B4 and LAG-3 
(Fig. 5, F and G). We next analyzed if the functionality of T. 
gondii–specific CD4 T cells correlated with their Blimp-1 
expression. Compared with the Blimp-1int population, Blimp-
1hi–expressing CD4 T cells exhibited decreased functionality 
in terms of their ability to produce both IFN-γ and TNF 
(Fig. 5, H and I). In total, these data suggest that elevated level 
of Blimp-1 in the PD-1hi is coupled to exhaustion of the T. 
gondii–specific CD4 T cells.
Control animals received equal number of CD4 T cells from naive donors. The recipient animals were infected the next day and proliferation was measured 
using a pulse-chase approach. BrdU was injected into the recipient mice starting 1 d after transfer, and the treatment was repeated alternatively for a 5-d 
period. Animals were sacrificed 1 d after final treatment. (D) Donor CD4 T cells in spleens were evaluated for BrdU incorporation by flow cytometry (top) 
and CD4/CD8 profile (bottom). (E) CD11ahiCD49dhi cells and CD11aloCD49dlo were gated then IFN-γ and TNF secretion was observed with TLA stimulation. (F) 
CD4+ IFN-γ+ cells were analyzed by CD11a and CD49d surrogate markers. (G) The graphs represent number of AS15 tetramer+ CD4 T cells and (H) number 
of CD11ahiCD49dhi CD4 T cells. The data represent three experiments with at least three mice per group (three experiments). P-values were obtained using 
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As earlier studies have shown that memory CD8 T cells 
are more prone to exhaustion (Bhadra et al., 2012), we next 
analyzed the pattern of expression of inhibitory receptor and 
transcription factor (PD-1 and Blimp-1) associated with T 
cell exhaustion in memory CD4 T cell subsets. CD4 effector 
memory (TEM; CD62LloCD44hi) or central memory (TCM; 
CD62LhiCD44hi) cells were evaluated for expression of PD-1 
and Blimp-1. As shown in Fig.  6, A and B, at the peak of 
exhaustion (7 wk p.i.), the TCM subset exhibited higher levels 
of Blimp-1 and PD-1 expression as compared with the TEM 
or cells bearing naive phenotype (Fig. 6, A and B). To further 
dissect the mechanism for the elevated expression of PD-1 on 
phenotypically defined memory T cells, we next examined the 
epigenetic program at the PD-1 promoter in naive and mem-
ory CD4 T cell subsets recovered from infected animals. This 
would determine if persistent T. gondii infection resulted in 
changes to the epigenetic program in T. gondii–specific CD4 
T cells. Bisulfite sequencing methylation analysis of the PD-1 
Figure 3. T. gondii–specific CD4 T cells express increased levels of inhibitory receptors during chronic infection. C57BL/6 mice were perorally 
infected with 10 ME49 tissue cysts. At 3, 5, and 7 wk p.i., absolute numbers of CD4+CD11ahiCD49dhicells in spleen (A, top) and brain (A, bottom) were eval-
uated. (B) PD-1 expression on CD4+CD11ahiCD49dhi cells in spleen and brain. Black line, CD4+CD11ahiCD49dhi; dotted line, CD4+CD11aloCD49dlo; gray filled, 
naive CD4+. (C) MFI of PD-1 expression at 3, 5, and 7 wk p.i. Circle, CD4+CD11ahiCD49dhi; square, CD4+CD11aloCD49dlo. (D) PD-1 levels on the cells expressing 
surrogate markers was measured and ratio of PD-1lo, PD-1Int, and PD-1hi was performed. (E) Multiple inhibitory receptor expression on CD4+CD11ahiCD49dhi 
T cells in PD-1lo, PD-1Int, and PD-1hi population. LAG-3 and 2B4 expression on splenic T. gondii–specific CD4 T cells (CD4+CD11ahiCD49dhi) at 7 wk p.i. Histo-
gram overlays show the frequency of PD-1hi CD4+CD11ahiCD49dhi T cells that coexpress LAG-3 or 2B4 at 7 wk p.i. (left). The mean percentage of PD-1+LAG-3+ 
or PD-1+2B4+ cells (right). The data represent three experiments with at least three mice per group. P-values were obtained using the Student’s t test. *, P 
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promoter was performed using genomic DNA isolated from 
purified naive and memory CD4 T cells from mice at 7 wk 
p.i. As expected, the PD-1 promoter in the TCM and TEM CD4 
T cell subsets were dramatically demethylated compared with 
naive CD4 T cells from infected animals (Fig. 6, C and D). In 
addition, corresponding with the pattern of PD-1 protein ex-
Figure 4. T. gondii–specific CD4 T cells exhibit signs of functional exhaustion during chronic infection. (A) Absolute number of functional 
(IFN-γ+TNF+) T. gondii–specific (CD11ahiCD49dhi) CD4 T cells at 5 and 7 wk p.i. in spleen and brain. (B) IFN-γ and TNF production of spleen and brain T. 
gondii–specific CD4 T cells was analyzed by gating on PD-1lo, PD-1Int, and PD-1hi subsets from spleen (left) and brain (right) at 7 wk p.i. (C) Frequency of 
functional (IFN-γ+TNF+) T cells in PD-1lo, PD-1Int, and PD-1hi subsets at 7 wk p.i. (D) Boolean gating analysis of the secretion of cytokines (IFN-γ+TNF+) by 
PD-1lo, PD-1Int, and PD-1hi at 7 wk p.i. (E) CD4+FoxP3+ (T reg) cells were detected in splenocytes at 3, 5, and 7 wk p.i. (F) Frequency of T reg cells represented 
by dot graph. The data represent three experiments with at least three mice per group. P-values were obtained using the Student’s t test. *, P < 0.05; **, P 
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Figure 5. Elevated Blimp-1 expression is directly correlated with increased inhibitory receptor expression and reduced functionality 
of T. gondii–specific CD4 T cells during chronic infection. (A) Representative histograms of T-bet, Eomes, Blimp-1, and BCL6 expression in T. 
gondii–specific CD4 T cells at 5 and 7 wk p.i. Gray filled, naive; gray line, 5 wk pi; and black thick line, 7 pi. (B) MFI at 5 and 7 wk p.i. gated on PD-1hi 
subset. (C) Analysis of T-bet, Eomes, and Bcl6 expression on Blimp-1hi population. (D) Gating strategy for analyzing Blimp-1lo, Blimp-1Int, and Blimp-
1hi expressing T. gondii–specific CD4 T cells. (E) PD-1 expression on Blimp-1lo, Blimp-1Int, and Blimp-1hi expressing cells (Black line, Blimp-1hi; dot 
line, Blimp-1Int; and gray filled, Blimp-1lo). (F) Multiple inhibitory receptors expression (PD-1, 2B4, and LAG-3) on Blimp-1lo, Blimp-1Int, and Blimp-1hi 
(G) Frequency of cells. (H) Functionality of Blimp-1lo, Blimp-1Int, and Blimp-1hi on T. gondii–specific CD4 T cells. (I) Percentage of IFN-γ+ cells and 
IFN-γ+TNF+. The data represent three experiments with at least three mice per group. P-values were obtained using the Student’s t test. *, P < 0.05; 
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pression, the methylation of PD-1 in the TEM was significantly 
greater than in the TCM (Fig. 6 E). These data indicate that the 
T. gondii–specific TCM phenotype, CD4 T cells had acquired 
a transcriptionally permissive epigenetic program at the PD-1 
promoter. Because the naive CD4 T cells from the infected 
animals had not acquired a demethylated PD-1 promoter, 
promoter demethylation in the T. gondii–specific CD4 T cell 
memory subsets is likely antigen mediated.
Prior studies have demonstrated that Blimp-1 expres-
sion enhances the terminal differentiation of CD8 T cells 
during LCMV infection (Rutishauser et al., 2009) and re-
presses the acquisition of memory cell properties by effec-
tor cells. Therefore, to assess the role of Blimp-1 in CD4 T 
cell exhaustion, ERT cre prdm1 fl/fl (cKO mice; Reinert 
et al., 2012; Neumann et al., 2014; Tellier et al., 2016), mice 
were treated with tamoxifen at 6 wk after T. gondii infec-
tion, and the deletion of transcription factor was established 
by flow cytometry. After Blimp-1 deletion, the phenotype 
and function of T. gondii–specific CD4 T cells (CD4+C-
D11ahiCD49dhi) were analyzed at 7 wk p.i. Interestingly, we 
observed a significant increase in the quantity of T. gon-
dii–specific CD4 T cells (CD4+AS15+ and CD11ahiCD49dhi) 
after tamoxifen treatment (Fig. 6 F, left). We next measured 
the effect of Blimp-1 deletion on the TEM and TCM subsets. 
Consistent with the greater degree of functional exhaustion 
in the TCM phenotyped cells, tamoxifen treatment resulted in 
a significant expansion in the percentage of TCM (CD44hiC-
D62hi) phenotyped cells as compared with TEM (CD44hiC-
D62lo) population (Fig. 6 F, right). Moreover, in the absence 
of Blimp-1, we also observed a significant reduction in PD-1 
expression of TCM population (Fig. 6, G and H). Collectively, 
these results demonstrate that the up-regulated expression 
of Blimp-1 results in the elevated expression of inhibitory 
receptors and is correlated with their reduced functionality 
during chronic T. gondii infection.
Recently, it has been reported that, compared with 
TEM, TCM have increased stem cell–like properties and can 
give rise to multiple effector and memory subsets upon 
antigen reencounter (Graef et al., 2014). Thus, increased 
expression of PD-1 by TCM, and their exhaustion, may com-
promise the host’s ability to maintain control of chronic T. 
gondii infection. In the intermediate host, T. gondii under-
goes stage conversion into a rapidly replicating tachyzoite 
that is responsible for reactivation of toxoplasmosis (Lyons 
et al., 2002; Bhadra et al., 2011). Tamoxifen treatment led 
to significant decreases in the tachyzoite numbers in brain, 
blood, and spleen (Fig. 6, I and J). To determine this effect 
was not related to tamoxifen, the treatment of wild-type 
mice with the drug had no effect (Fig. 6 I). In spleen, anal-
ysis of the frequency of tachyzoite in the leukocyte subsets 
revealed that the parasite preferentially infected CD11c+, 
CD11b+, Macrophage (F4/80+), and B cells, and tamoxifen 
treatment led to decreased cell infection in the cKO mice 
(Fig.  6  K). Collectively, these findings suggest that condi-
tional deletion of Blimp-1 in the mice carrying chronic T. 
gondii infection results in the reduction of PD-1 expression 
on TCM CD4 T cells, which leads to better parasite con-
trol by the infected host.
The role of Blimp-1 in the exhibition of T. gondii–specific 
CD4 T cell exhaustion is cell intrinsic
The aforementioned data bear the implication that absence 
of Blimp-1 affects both the quantity and quality of CD4 T 
cell response. However, it does not explain if CD4 T cell–
intrinsic Blimp-1 expression in vivo can elicit a similar ef-
fect. Moreover, it does not rule out if Blimp-1 expression 
on other cell types via changes in microenvironment such 
as cytokine milieu or antigen burden affecting CD4 T cells. 
Next, to determine if Blimp-1 plays a cell-intrinsic role in 
CD4 T cell dysfunction, mixed bone marrow chimeras be-
tween WT and Blimp-1 conditional knock out (ERT cre 
Prdm1 fl/fl) at 1:1 ratio (WT/cKO mice) were generated 
(Fig.  7  A). The chimeras were infected and treated with 
tamoxifen for 1wk starting at 4 wk p.i. Flow cytometric 
assay was performed to confirm that treatment abrogates 
Blimp-1 expression in the CD4 T cells (Fig. 7 B). At 5 wk 
p.i., PD-1 and T-bet expression on T. gondii–specific CD4 
T cells was measured. We observed that Blimp-1–deficient 
CD4 T cells had decreased levels of PD-1 and increased 
T-bet expression as compared with WT cells (Fig.  7  C). 
Furthermore, measurement of the cytokine profile 
(IFN-γ+TNF+) revealed that the T. gondii–specific CD4 T 
cells from the cKO had increased functionality as compared 
with WT cells (Fig.  7, D and E). These data demonstrate 
that Blimp-1 plays a cell-intrinsic role in mediating T. gon-
dii–specific CD4 T cell dysfunction.
T gondii–specific CD4 T cells help to reduce CD8 T cell 
exhaustion in mice carrying chronic T. gondii infection
Because CD4 T cells play an important role in generation 
of functional CD8 T cell responses (Bevan, 2004), we next 
determined if the dysfunctional state of CD4 T cells during 
chronic toxoplasmosis influenced CD8 T cell response. To ex-
plore this hypothesis, T. gondii–specific and nonspecific CD4 
T cell populations were isolated from mice at 2 wk p.i. and 
transferred into distinct congenically marked recipients that 
were infected 5 wk before transfer (Fig. 8 A, left). The donor 
population was recoverable at 2 wk after transfer as shown in 
Fig. 8 (right). Antigen specificity of CD8 T cells was mea-
sured by surrogate marker (CD11a and CD44) expression 
(Masopust et al., 2007), which was validated by using class I 
tetramer (Tg057; unpublished data). Similar to antigen–spe-
cific CD4 T cells, CD8+Tg057+ cells coexpressed CD11a and 
CD44 and the population secreted higher levels of IFN-γ 
than CD11loCD44lo (unpublished data). Furthermore, major-
ity of splenic IFN-γ+GranzymeB+ CD8 population expressed 
CD11ahiCD44hi in spleen (unpublished data). At 7 wk p.i., the 
CD8 T cells from the spleen and brain of recipient mice were 
evaluated for expression of various inhibitory receptors and 
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Figure 6. Central memory-phenotype CD4 T cells are preferentially exhausted during chronic T. gondii infection. (A) PD-1 and Blimp-1 
expression in naive, TEM, and TCM CD4 T cells at 7 wk p.i. (B) MFI of PD-1 and Blimp-1. (C) Bisulfite sequencing methylation analysis of the PD-1 
regulatory region in naive and T. gondii–specific CD4 T cells (CD4+CD11ahiCD49dhi) at wk7 p.i. Genomic DNA was isolated from FACS-purified naive 
(CD4+CD11aloCD49dloCD44loCD62hi) and memory CD4 T cell subsets (TEM, CD4+CD11ahiCD49dhiCD44hiCD62Llo vs. TCM, CD4+CD11ahiCD49dhiCD44hiC-
D62Lhi). Genomic DNA was bisulfite treated and PCR amplified using PD-1 locus-specific primers. (D) Each horizontal line represents an individual 
sequenced clone. (E) CpG methylation rate of TEM and TCM in PD-1 regulatory region. Filled circles, methylated cytosine. Open circles, demethylated 
cytosine. (F) ERT cre prdm1fl/fl (cKO) mice were injected by tamoxifen at 6 wk p.i., mice were sacrificed at 7 wk p.i. Cells were stained with CD4 
and MHC II-restricted tetramer (AS15) and gated on T. gondii–specific CD4 T cells (CD4+CD11ahiCD49dhi, left). TEM and TCM were analyzed by CD62L 
and CD44. (G) PD-1 expression between TEM and TCM with tamoxifen treatment. (H) Overlay PD-1 expression on TCM with tamoxifen to nontreated 
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gondii–specific CD4 T cells significantly reduced PD-1 ex-
pression on T. gondii–specific CD8 T cells in both spleen and 
brain of recipient mice relative to animals receiving nonspe-
cific CD4 T cells. (Fig. 8, B and C). T. gondii–specific CD8 T 
cells from the recipients treated with T. gondii–specific CD4 
T cell exhibited increased T-bet (Fig. 8 B, panel 2), and de-
crease in Eomes and Blimp-1 expression (Fig. 8 B, panel 3 
and 4). Additionally, treatment with T. gondii–specific CD4 
T cells also enhanced the proliferation of T. gondii–specific 
CD8 T cells both in spleen and brain as measured by Ki67 
expression (Fig. 8, B [panel 5] and C [panel 2]). Changes in 
the expression of PD-1, transcription factors, and prolifera-
tion of CD8 T cells from mice receiving T. gondii–specific 
CD4 T cells was also reflected by MFI (unpublished data). 
Transfer of T. gondii–specific CD4 T cells also increased the 
functionality of T. gondii–specific CD8 T cells in recipient 
mice, as defined by cytokine and Granzyme expression. In-
deed, T. gondii–specific CD8 T cells from treated animals had 
increased IFN-γ and GranzymeB expression (Fig. 8 D). Sur-
prisingly, transfer of nonexhausted T. gondii–specific CD4 T 
cells (CD45.2) did not significantly alter PD-1 or Blimp-1 
expression or functionality (IFN-γ and TNF production) of 
recipient CD4 (CD45.1) T cells (Fig. 8, B–D). Thus, it is im-
portant to note that nonexhausted T. gondii–specific CD4 T 
cells help to rescue T. gondii–specific CD8 T cells, but not 
CD4 T cells, during advanced T. gondii infection.
Conditional deletion of Blimp-1 on CD4 T cells reduces 
CD8 T cell dysfunctionality and controls the reactivation of 
latent T. gondii infection
The aforementioned studies demonstrate that conditional de-
letion of Blimp-1 restores CD4 T cell helper function. We next 
graph representing infected population in brain, blood, and spleen. (K) Percentage of infected mononuclear cells in spleen were evaluated. The data 
represent three experiments with at least three mice per group. P-values were obtained using the Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 
0.001; ****, P < 0.0001 (mean ± SEM).
Figure 7. The intrinsic role of Blimp-1 
in T. gondii–specific CD4 T cells during 
chronic infection. (A) Bone marrow cells 
purified from WT (CD45.1) and cKO (CD45.2) 
mice were transferred at 1:1 ratio to irradiated 
(800 rad) CD45.1 animals. 8 wk after trans-
fer, the chimeric mice were infected perorally 
with 10 cysts. At 4 wk p.i., recipient mice 
were treated with tamoxifen for 5 d and 1 wk 
later, the animals were sacrificed. (B) Blimp-1 
expression on T. gondii–specific CD4 T cells 
(CD4+CD11ahiCD49dhi, dotted line) from WT 
animals, T. gondii–specific CD4 T cells (CD4+C-
D11ahiCD49dhi, black line) from cKO mice and 
CD4 T cells from naive mice (gray filled) after 
tamoxifen treatment. (C) PD-1 and T-bet ex-
pression on T. gondii–specific CD4 T cells (dot-
ted line, infected BMC; thick line, infected BMC 
with tamoxifen treatment; gray filled, naive B6 
mice). (D and E) IFN-γ and TNF production of 
splenic T. gondii–specific CD4 T cells. The data 
represent three experiments with at least three 
mice per group. P-values were obtained using 
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determined if deletion of this transcription factor specifically 
reverses exhaustion of CD4 T cells and subsequently restores 
CD8 T cell functionality. To address a CD4 T cell–intrinsic 
mechanism for Blimp-1–mediated CD4 T cell exhaustion, 
adoptive transfer of cKO CD4 T cells into CD4 T cell–defi-
cient mice was performed and reactivation of infection was 
monitored. CD4 T cells from cKO mice were purified and 
transferred into CD4 T cell–deficient mice (CD4 KO). The 
recipient animals were infected and treated with tamoxifen at 
6 wk p.i. (Fig. 9 A). 1 wk later, animals were sacrificed and 
inhibitory receptors (Fig.  9, B and E), transcription factors 
(Fig.  9, C and F), and co-stimulatory receptors (Fig.  9, D 
and G) on recipient cerebral CD8 T cells were measured. As 
shown in Fig. 9 (B and E), deletion of Blimp-1 on CD4 T 
cells reduced the inhibitory receptors such as PD-1, CD160, 
and LAG-3 on T. gondii–specific CD8 T (CD11ahiCD44hi) 
cells, whereas co-stimulatory receptor (41BB) expression was 
up-regulated (Fig.  9, D and G). As expected, we observed 
down-regulation of inhibitory receptors and increased T-bet 
expression. Transcription factors (Blimp-1 and Eomes) were 
decreased on T. gondii–specific brain CD8 T cells as a result 
of tamoxifen treatment, indicating the reversal of exhaustion 
(Fig. 9, C and F). We next examined the ability of Blimp-1 
conditional deletion to restore the functionality of recipient 
CD8 T cells. Indeed, Blimp-1 conditional deletion of CD4 
T cells resulted in a significant increase in the population of 
polyfunctional CD8 T cells (GranzymeB+, IFN-γ+, and TNF+; 
Fig.  9, H–J). Blimp-1 has been reported to repress inflam-
matory cytokines like IL-2 and IL-21 (Martins et al., 2008; 
Johnston et al., 2009) and induce IL-10 (Neumann et al., 
Figure 8. Transfer of T. gondii–specific 
nonexhausted CD4 T cells reverses CD8 T 
cell response. (A) Transfer strategy of T. gon-
dii–specific nonexhausted CD4 T cells to mice 
carrying chronic infection (left). CD45.2 B6 
animals (infected 5 wk before transfer) were 
treated with T. gondii–specific nonexhausted 
CD4 T cells (CD4+CD11ahiCD49dhi) or nonspe-
cific CD4 T cells (CD4+CD11aloCD49dlo) from 
CD45.1 donors. The cells from the donor mice 
were isolated at 2 wk p.i. and each recipient 
received 1 × 106 cells. Restoration of donor cell 
population in recipient mice (right). (B) T. gon-
dii–specific splenic CD4 and CD8 population 
were analyzed for the expression PD-1, T-bet, 
Eomes, Blimp-1, and Ki67. (C) brain CD4 and 
CD8 T cells were assayed for PD-1 and Ki67 
expression. (D) Polyfunctionality of T. gon-
dii–specific CD8 T cells (CD8+CD11ahiCD44hi) 
and CD4 T cells (CD4+CD11ahiCD49dhi) in mice 
receiving nonexhausted T. gondii–specific CD4 
T cells. The data represent three experiments 
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2014; Parish et al., 2014), a functionally suppressive cytokine. 
The evaluation of cytokine levels in the sera of the recipient 
mice treated with Blimp-1 deleted donor CD4 population 
was performed (Fig. 9, K–M). Interestingly, IL-2 and IL-21 
were up-regulated and IL-10 was decreased in these animals. 
This suggested that these cytokines might be capable of help-
ing T. gondii–specific CD8 T cell recover their proliferation 
and survival (IL-2) and maintain the memory function (IL-
21) and escape from the suppressive cytokine (IL-10) released 
during chronic infection. As the reactivation of chronic toxo-
plasmosis leads to encephalitis, next the T. gondii–specific 
CD8 T cell response in the recipient animals treated with 
tamoxifen was assayed. As shown in Fig.  10  A, the donor 
CD4 T cell population was recovered in all tissues (blood, 
brain, and spleen) at 7 wk p.i. To determine if the increase in 
the T. gondii–specific CD8 (CD8+CD11ahiCD49dhi) T cell 
poly-functional response translated into enhanced control 
of the parasite, the brains were assayed for the tachyzoites. 
As shown in Fig. 10 (B and C), significantly fewer parasites 
were detected in the tissues (blood, brain, and spleen) of re-
cipients where donor CD4 T cells were deleted of Blimp-1. 
Tachyzoite–bradyzoite interconversion is believed to play a 
central role, not only in establishing the chronic infection, but 
also in disease recrudescence (Lyons et al., 2002; Bhadra et al., 
2011). To further address if deletion of Blimp-1 results in con-
trol of infection, we performed confocal microscopic analysis 
using anti-SAG1 antibody (specific for tachyzoite antigen) 
to detect infected cells. Consistent with the flow cytometric 
data, the deletion of Blimp-1 on the donor CD4 T cells led to 
a decrease of tachyzoites in brain (Fig. 10 D). These findings 
suggest that the increase in inflammatory cytokines produced 
primarily by CD4 T cells may contribute in providing the 
help needed to maintain the functionality of an antigen-spe-
cific CD8 T cell population during chronic toxoplasmosis.
DIS CUS SION
During chronic toxoplasmosis, CD4 T cells are believed to 
play an important secondary role by providing help to CD8 
T cells, which are considered a primary effector population 
responsible for keeping the infection under control (Gazzi-
nelli et al., 1992; Casciotti et al., 2002). Indeed, CD4 T cells 
have been described as an important source of IFN-γ during 
the acute phase of infection (Gazzinelli et al., 1991, 1992); 
however, their contribution in maintaining the chronicity of 
infection is not well defined. Earlier studies from our labo-
ratory reported that a robust CD8 T cell immune response 
developed during T. gondii infection, but was unable to pre-
vent the reactivation of latent infection in susceptible animals 
(Bhadra et al., 2011, 2012). This was attributed to increased 
expression of inhibitory receptors on CD8 T cells, which 
led to their dysfunctionality and subsequent reactivation of 
chronic infection in the host. However, the underlying causes 
for CD8 T cell dysfunction during chronic infection have not 
been explored. In this report, we demonstrate that the CD4 T 
cell subset during chronic toxoplasmosis gets exhausted due 
to increased Blimp-1 expression by these cells. We demon-
strate that lack of adequate CD4 T cell help due to increased 
Blimp-1 expression is the primary cause of CD8 T cell ex-
haustion and that deletion of this transcription factor reverses 
CD8 T cell dysfunctionality and enhances host ability to 
contain chronic infection.
CD8 T cell exhaustion was first reported in mice in-
fected with the chronic strain of LCMV (Zajac et al., 1998) 
and was subsequently extended to other persistent viral in-
fections and cancer (Barber et al., 2006; Yi et al., 2010; Speiser 
et al., 2014; Pauken and Wherry, 2015). Recently, CD8 T cell 
exhaustion has also been reported during chronic parasitic 
infections, such as T. gondii and Plasmodium, as well as in 
mice infected with Leishmania (Hernández-Ruiz et al., 2010; 
Bhadra et al., 2011; Horne-Debets et al., 2013). In addition 
to CD8 exhaustion, CD4 T cell exhaustion has been reported 
during HIV, LCMV, and HCV infection (Fletcher et al., 2005; 
Day et al., 2006; Kasprowicz et al., 2008; Crawford et al., 2014; 
Morou et al., 2014). CD4 T cells have been reported to ex-
press inhibitory receptors during chronic infections similar to 
exhausted CD8 T cells (Butler et al., 2011; Mou et al., 2013), 
although there are differences in the degree of expression and 
some receptors like CTLA4 are biased toward CD4 T cells 
(Crawford et al., 2014).
However, the status of CD4 T cells and how they respond 
during chronic T. gondii infection has not been extensively 
evaluated. In this study, we observed that T. gondii–specific 
CD4 T cells during chronic infection exhibit increased ex-
pression of inhibitory receptors (PD-1, LAG-3, and 2B4) 
concomitant with decreased functionality, as shown by IFN-γ 
and TNF production. Remarkably, examination of inhibitory 
receptors and co-stimulatory receptors at early chronic in-
fection revealed that CD4 T cell dysfunction is more pro-
nounced than CD8 T cells. Similar to the studies performed 
with exhausted CD8 T cells during viral infection (Shin et al., 
2009), Blimp-1 was highly up-regulated on T. gondii–specific 
PD-1hi CD4 T cells during chronic T. gondii infection. In-
terestingly, as compared with CD4 TEM, Blimp-1 was increas-
ingly expressed on CD4 TCM, which was correlated with the 
high PD-1 expression by this subset. As long-term immunity 
against pathogens is attributed to TCM population (Zaph et al., 
2004; Pakpour et al., 2008), these findings identify a poten-
tially serious flaw in the maintenance of immune-protection 
against the parasite in the animals carrying chronic infection 
due to defect in the TCM population.
The critical role of Blimp-1 in CD4 T cell exhaustion/
dysfunctionality was established by using conditional knock-
out mice for this transcription factor. Deletion of Blimp-1 in 
these animals reduced the expression of inhibitory factors on 
T. gondii–specific CD4 T cells, increased their functionality 
and ultimately led to better control of infection as demon-
strated by the number of tachyzoites in various tissues.
Furthermore, our data demonstrates that CD8 T cell 
dysfunctionality is linked to CD4 T cell exhaustion. Adop-
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Figure 9. Deletion of Blimp-1 on CD4 T cells reverses T. gondii–specific brain CD8 T cell exhaustion. (A) Purified CD4 T cells (1 × 107) from 
cKO were transferred to CD4-deficient mice. The recipients were infected with 10 cysts of T. gondii and at 6 wk p.i. tamoxifen was administered to 
a group of recipients. (B) PD-1, CD160, and LAG-3 (inhibitory receptors). (C) T-bet, Blimp-1, and Eomes (transcription factors). (D) 41BB and ICOS 
(co-stimulatory receptors) expression on T. gondii–specific CD8 (CD8+CD11ahiCD44hi) T cells in brain of recipient mice. (E) MFI of inhibitory receptors, 
(F) transcription factors, and (G) co-stimulatory receptors in T. gondii–specific CD8 T cells in brain. (H) Intracellular IFN-γ, TNF, and GranzymeB pro-
duction of T. gondii–specific CD8 T cells in brain. (I) Boolean gating analysis with proportion of polyfunctional (IFN-γ, GranzymeB, and/or TNF) CD8 T 
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elevated T-bet levels and decreased PD-1 and Blimp-1 ex-
pression on T. gondii–specific CD8 T cells. More importantly, 
the transfer of nonexhausted CD4 T cells increased the po-
ly-functionality of T. gondii–specific CD8 T cell population 
in the recipient mice and decreased parasite burden. Inter-
estingly, in contrast to the effect on CD8 T cells, the trans-
fer of nonexhausted CD4 T cells had minimal effect on the 
CD4 population from the recipient animals and no changes 
in terms of inhibitory receptor expression or functionality 
was noted. The precise mechanism by which CD4 T cells res-
cue CD8 T cell dysfunction is not well defined, but may be 
attributed to number of factors like CD40-40L pathway, CD4 
as bar graphs (K–M). Serum was obtained by tail bleeding and analyzed for IL-2, IL-10, and IL-21 at wk7 p.i. by enzyme-linked immunosorbent assay 
(ELI SA). Bar graph represents cytokine production (IL-2, IL-10, and IL-21), respectively at 7 wk p.i. The data represent three experiments with at least 
three mice per group. P-values were obtained using the Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (mean ± SEM).
Figure 10. Deletion of Blimp-1 on CD4 T cells inhibits parasites load during chronic stage of the infection. (A) CD4/CD8 profile in CD4KO-recipient 
mice in blood, brain, and spleen. (B) Flow cytometric analysis of T. gondii–infected cells in blood, brain, and spleen on the samples gated on leukocytes. The 
assay was performed at 7 wk p.i. Bars, 5 µm. (C) Percentage of T. gondii–infected cells in each organ. (D) Tachyzoites were examined by anti-SAG (p30) with 
confocal microscopy. The data represent three experiments with at least three mice per group. P-values were obtained using the Student’s t test. *, P < 0.05; 
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and CD8 direct interaction, indirect DC help or cytokine 
effect (Bennett et al., 1997, 1998; Ozaki et al., 2002; Wilson 
and Livingstone, 2008; Wiesel and Oxenius, 2012). The roles 
of CD4 T cells in maintaining CD8 functionality may also be 
dependent on the nature of infection.
Another interesting finding is that exhausted CD4 T 
cells may have a defect in trafficking to the brain, which is 
an important site of T. gondii infection. In adoptive transfer 
studies, we observed that the reconstitution rate of Blimp-1 
expressing exhausted CD4 T cell in brain was approximately 
twofold less than Blimp-1–deleted cells, whereas no differ-
ences in circulating CD4 T cell population in blood were 
observed (Fig. 10 A). In support of this data, decreased CD4 
T cell recruitment in the brain was further confirmed with 
a confocal study that demonstrated that deletion of Blimp-1 
on CD4 T cells led to their increased migration to the brain 
(Fig.  10  A). It is important to mention that decreased ex-
pression of CXCR3, a chemokine receptor, was observed on 
T. gondii–specific, antigen-specific CD8 T cells expressing 
high levels of PD-1 (unpublished data). A critical role of the 
chemokine receptor CXCR3 and its ligand CXCL-10 in the 
migration of CD8 T cells to the brain tissue during T. gondii 
infection has been reported (Khan et al., 2000; Harris et al., 
2012). Thus, it is important to conduct studies that will address 
the issue of the ability of PD-1hi and/or Blimp-1hi–expressing 
T cell migration to functional sites of T. gondii infection.
In conclusion, our results reveal that during chronic in-
fection, T. gondii–specific CD4 T cells express functional and 
phenotypic exhaustion, including reduced cytokine secretion 
and increased expression of multiple inhibitory receptors. In-
terestingly, this dysfunctionality is more pronounced on the 
TCM subset of the CD4 T cell population. Remarkably, con-
ditional deletion of Blimp-1 on CD4 T cells rescued CD8 
T cell exhaustion and led to efficient control of parasite load 
in the infected host, linking CD8 T cell dysfunctionality to 
increased Blimp-1 expression on CD4 T cells. Our findings 
have important implications in HIV-infected individuals, in 
whom reduced CD4 T cell numbers are known to cause re-
activation of latent infection (Sainz et al., 2013; Serrano-Vil-
lar et al., 2014). In addition to reduced CD4 T cell counts, 
dysfunctionality of these cells in these individuals may fur-
ther compromise their ability to provide essential help to 
CD8 T cells that, as shown in (Fig. Figs 8–10), are primary 
effector cells against this opportunistic pathogen. Further-
more, Blimp-1 may be an important target for vaccination 
studies where the TCM population needs to be maintained 
for long-term protection.
MAT ERI ALS AND MET HODS
Mice
6–8-wk-old female C57BL/6, B6.SJL(CD45.1), ERT cre, 
prdm1 fl/fl, CD4-deficient mice were purchased from Jack-
son laboratories. For generation of cKO (ERT cre Prdm1fl/
fl) mice, ERT cre and prdm1 fl/fl cKO mice were bred. 
Animal studies were performed in agreement with Institu-
tional Animal Care and Use Committee (IAC UC)–approved 
guidelines at George Washington University Medical Center. 
All experiments were approved by the George Washington 
University Medical Center Animal Resource Facility IAC 
UC under protocol approval number A052 in accordance 
with the American Association for Accreditation of Lab Ani-
mal Care certified guidelines.
Parasites and infection
T. gondii cysts of ME49 strain were prepared from the brains 
of infected mice. Animals were infected with 10 cysts per 
mouse via intragastric route and sacrificed by CO2 inhalation 
at 3, 5, or 7 wk after infection. T. gondii lysate antigen (TLA) 
was extracted from RH strain of parasite and preparation was 
performed as previously described (Khan and Kasper, 1996).
Tamoxifen preparation and administration
Tamoxifen (Sigma-Aldrich; T5648) was dissolved in corn oil 
to make solutions of 20 mg/ml, which were subsequently 
protected from light. The solutions were freshly prepared 
the day before each injection and dissolved overnight at 
room temperature. Recipient mice were administered the 
drug via peroral route at the dosage of 1 mg/animal every 
24 h over a 5-d period.
Lymphocyte isolation and fluorescent antibody staining
Single-cell suspensions were prepared from spleen and brain of 
mice. Red blood cell lysis was performed to remove red blood 
cells from spleen cell suspensions. Brains were individually 
washed in PBS, and then passed through a 70-µm cell strainer, 
followed by gradient centrifuge (2,000 rpm for 20 min) in 
30% Percoll solution containing 100 IU/ml of heparin. Pellet 
was then resuspended in cold PBS-2% FCS. The following 
antibodies were used in cell surface staining and intracel-
lular staining of lymphocytes: CD4(GK1.5), CD8β (H35-
17.2), PD-1 (RMP-1), LAG-3 (C9B7W), 2B4 (eBio244F4), 
CD45.1 (A20), CD45.2 (104), CD11a (M17/4), CD49d 
(R1-2), CD44 (IM7), CD62L(MEL-14), T-bet (eBio4B10), 
Eomes (Dan11mag), IFN-γ (XMG1.2), Ki-67 (SolA15), TN-
F(MP6-XT22), GranzymeB (NGZB), and Ki-67 (SolA15) 
were obtained from Affymetrix eBioscience. Blimp-1 (5E7) 
was purchased from BD. For intracellular staining for tran-
scription factors, surface staining was performed, and then 
fix/perm buffer (eBioscience) were used. Next, T-bet, Eomes, 
Blimp-1, and BCL6 were stained after fixation.
Cell fluorescence was measured with a Cytek upgraded 
eight-color FAC SCalibur cytometer (BD), which accounts 
for differences in fluorescence scale. Data were analyzed using 
FlowJo (Tree Star) software.
Intracellular cytokine detection
For cytokine detection, restimulation was performed for 20 h 
with 20 µg/ml of TLA in supplemented Iscove’s Complete 
DMEM at 37°C in 5% CO2. Monensin (BD) was added 
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cells were then fixed using IC Fixation Buffer (Invitrogen) 
for 10 min. For detection of intracellular cytokines, cells 
were permeabilized by washing once with IC Permeabili-
zation Buffer (Invitrogen). Next, cells were resuspended in 
IC Permeabilization Buffer and stained with anti-cytokine 
antibodies for 60 min at 4°C.
Cell purification and enrichment
Purified T cell populations were obtained from spleens using 
a magnetic bead/column system EasySep biotin selection kit 
(StemCell Technologies). CD4 T Cells were isolated by first 
labeling total splenocytes with anti-B220 biotin, anti-CD19 
biotin, anti-CD11b biotin, anti-NK1.1 biotin, anti-Gr1 biotin, 
anti-Ter119 biotin, and anti Ly6G biotin. CD4+ cells (unlabeled 
fraction) were isolated by magnetic columns after being washed 
and labeled with streptavidin microbeads. Purity was >90%.
Flow cytometric detection of T. gondii–infected cells
Single-cell suspensions were performed by surface staining. 
After permeabilization, staining with FITC-labeled poly-
clonal anti-Toxoplasma antibody (Abcam) was performed, 
followed by incubation with biotinylated anti-FITC antibody 
(FIT-22; BioLegend) and subsequent labeling with Strepta-
vidin FITC (eBioscience).
Generation of mixed bone marrow chimeras
Bone marrow was extracted from cKO (CD45.2) and B6.SJL 
(CD45.1) mice, as previously described (Bhadra et al., 2014), 
and 5 × 106 total cells (at a 1:1 ratio for WT/cKO) were 
injected i.v. into lethally irradiated recipients (8 Gy/20  g 
body weight). Recipient animals received sulfamethoxaz-
ole- and trimethoprim-supplemented (Hi-Tech Pharmacal) 
water for 5 wk after transfer. Experiments were performed 8 
wk after reconstitution.
PD-1 methylation analysis
DNA was isolated from FACS-purified T cell. Purified 
DNA was then bisulfite modified using the Zymo EZ DNA 
Methylation-Gold kit per the manufacturer’s protocol. Bisul-
fite-modified DNA was then PCR amplified using Jumpstart 
Taq and published primers (Youngblood et al., 2011). The 
PCR amplicon was gel purified and cloned into the pGEM 
T-easy cloning vector. The vector was then transformed into 
XL-10 ultracompetent bacteria and colonies containing a 
vector with an insert were picked based on blue-white screen-
ing. The PCR insert from individual bacterial colonies was 
sequenced and the allelic frequency of cytosine preservation 
was determined by sequencing cloned vectors from many in-
dividual colonies. Cytosine preservation after bisulfite treat-
ment (methylated) is represented as filled circles in the figure.
Immunohistochemistry and confocal imaging
T. gondii–infected frozen brain (5 µm) were fixed for 30 min 
with 4% buffered paraformalin, permeabilized with 0.2% Tri-
ton ×100 for 20 min and blocked with 1% BSA at 4°C. The 
samples were incubated with the primary antiserum (anti-
SAG-1at 1:100 dilution) overnight at 4°C, and subsequently 
treated with secondary antiserum (fluorescein anti–mouse 
IgG at 1:100; L. Weiss, Albert Einstein College of Medicine, 
Bronx, NY) for 1 h at room temperature. For nuclear stain-
ing, the samples were treated with DAPI-NucBlue fixed cell 
stain Ready probes reagent (Molecular Probes). The analysis 
was performed with a spinning confocal system (Zeiss) with 
a scanning stage used to generate four-channel image sets 
controlled by Zen 2012 software. Images were captured with 
150×/1.4 Plan Apochromat objective lens (Zeiss) at pixel size 
of 0.14 µm and pixel dwell time of 0.8 ms.
ELI SA
Serum was taken from the tail bleed of T. gondii–infected 
mice at 7 wk p.i. The levels of cytokines (IL-2, -10, and -21) 
in the sera were determined by ELI SA using commercially 
available kits (eBioscience).
Statistical analysis
Differences in percentage, absolute number, and MFI for each 
experiment were evaluated using Student’s t test with P < 
0.05 taken as statistically significant. Error bars in graphs rep-
resent standard deviation. All computations were performed 
using GraphPad Prism Software.
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